Erganeo
Erganeo is a SATT (Societe d'Acceleration du Transfert de Technologies) founded January 26 2012 in Paris (SIREN 539868224 SAS HQ 30 rue de Gramont 75002 Paris), funded by the French State through the Programme d'Investissements d'Avenir (PIA) and Secretariat General pour l'Investissement (SGPI). Erganeo covers 350+ Ile-de-France laboratories and around 20K researchers across Universite Paris Cite + Sorbonne Paris Nord + INALCO + EPST partners (CNRS INSERM INRIA Institut Pasteur AP-HP) via the ValoCite consortium. Around EUR 47.3M of public capital deployed since inception, creating 38 deeptech startups financing 236 projects and signing 140 licenses across biotech infotech and enertech. Confirmed exits Brainvectis 2020 to Asklepios BioPharmaceutical and Open Agora 2020 to Jamespot.
Key facts
Recent exits
Coverage notes
1 fund tracked, 32 portfolio companies (30 active · 2 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Erganeo has raised, with its portfolio companies. Hand-checked from public filings.
ErganeoVC2012 · 14yr€47M30 active · 2 realized
Unrealized
30 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| AbilyCare | Healthcare | France | 2021 |
| Argument Theory | Software | France | 2019 |
| Augmented Endoscopy | Healthcare | France | 2019 |
| Auressens | Healthcare | France | 2021 |
| Carboneo | Energy | France | 2020 |
| Cobot One | Industrials | France | 2021 |
| Dextrain | Healthcare | France | 2012 |
| Ermium Therapeutics | Healthcare | France | 2019 |
| EVerZom | Healthcare | France | 2019 |
| Evora Biosciences | Healthcare | France | 2020 |
| Frema | Healthcare | France | 2020 |
| HephIA | Software | France | 2021 |
| Icon Photonics | TMT | France | 2018 |
| IZONICS | Industrials | France | 2022 |
| Kastafiore | Healthcare | France | 2020 |
| Lytid | TMT | France | 2018 |
| Methys Dx | Healthcare | France | 2021 |
| MilliDrop | Healthcare | France | 2015 |
| Neurallys | Healthcare | France | 2020 |
| Orixha | Healthcare | France | 2019 |
| PegmaTiss BioTech | Healthcare | France | 2023 |
| Persea | Healthcare | France | 2022 |
| Sequencia | Software | France | 2021 |
| SideROS | Healthcare | France | 2019 |
| SkinDermic | Healthcare | France | 2018 |
| Soléo-Ecosolutions | Industrials | France | 2016 |
| Telomium | Healthcare | France | 2020 |
| uGetWin | TMT | France | 2021 |
| Wastemy | Industrials | France | 2021 |
| WINTS | Software | France | 2021 |
Realized
2 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Brainvectis | Healthcare | France | 2015 | 2020 | Trade Sale | – | |
| Open Agora | Software | France | 2017 | 2020 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Erganeo
Erganeo is a venture capital platform based in Paris with capital deployed across 2 active fund vehicles and a founding year of 2012. The firm targets European and selectively global technology companies across healthcare, software, TMT and energy, with capital deployed across early-stage and Series A/B rounds alongside institutional limited partners.
Investment thesis
The platform deploys venture capital into healthcare, software, TMT and energy categories with a focus on technology-enabled businesses across France and selectively across Europe. Investment focus spans seed and growth stages with capital deployed across multiple rounds per portfolio company, supporting founder teams through international scaling and selective M&A activity. The fund structure enables longer holding periods than typical venture vehicles, supporting category-leadership outcomes in technology platforms with global ambitions.
Recent activity
Recent realised exits include Carboneo (energy, 2024), Methys Dx (healthcare, 2023), Argument Theory (diversified sectors, 2022) and HephIA (software, 2022). The platform tracks 2 fund vehicles, 22 active portfolio companies and 6 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€196.0BFrance·€13.2BFrance·€6.7BFrance·€4.3BFrance·€4.0BFrance·€4.0BFrance·€3.0BFrance·€2.8BFrance·€2.6BFrance·€2.5BFrance·€2.1BFrance·€2.0B